Cogent Biosciences, Inc.

NASDAQ:COGT

Biotechnology

Healthcare
$27.74 +2.60%

+$0.88 today

Market cap
$4.83B
Beta
0.35
P/E (TTM)
-6.6
EPS (TTM)
-$5.26
52W Low $6.92High $43.73

Volume 1.68M

Average 2.15M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$333.36M

FY 2025 · Annual

Net Income

-$328.94M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00004.62M
Gross Profit0000(4.62M)
Gross Margin—————
Research & Development55.91M121.63M173.76M232.66M269.78M
Selling, General & Admin19.64M26.21M34.38M43.28M63.58M
Operating Expenses75.55M147.84M208.13M275.94M328.74M
Depreciation & Amortization147K5.88M3.59M4.35M4.58M
EBITDA(72.13M)(130.37M)(188.82M)(251.51M)(321.29M)
EBITDA Margin—————
Operating Income(75.55M)(147.84M)(208.13M)(275.94M)(333.36M)
Operating Margin—————
Interest Income467K3.99M13.08M18.09M14.69M
Interest Expense03.99M003.06M
Other Income / Expenses3.28M7.6M15.72M20.08M4.43M
Income Before Tax(72.27M)(140.24M)(192.41M)(255.86M)(328.94M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(72.27M)(140.24M)(192.41M)(255.86M)(328.94M)
Net Margin—————
EPS (Basic)(1.85)(2.26)(2.42)(2.32)(2.04)
EPS (Diluted)(1.85)(2.26)(2.42)(2.32)(2.04)
Weighted Avg Shares38.73M58.74M79.66M110.46M160.98M
Weighted Avg Shares (Diluted)38.73M58.74M79.66M110.46M160.98M

COGT Earnings Waterfall · TTM

NASDAQ:COGT · Revenue to Net Income

Key Ratios

EPS$-2.31
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-13.9
P/S Ratio0.0

Analysis

$0 of revenue converted into -$377.2M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-2.31, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
4Statement of changes in beneficial ownershipOct 5, 2026
8-KCurrent reportSep 2, 2026
4Statement of changes in beneficial ownershipAug 31, 2026

How much revenue does COGT generate?

Cogent Biosciences, Inc. (COGT) reported $0.00 of revenue in fiscal 2025.

Is COGT profitable?

Cogent Biosciences, Inc. (COGT) reported -$328.94M of net income.